averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IRF2
|
ENSG00000168310.6 | interferon regulatory factor 2 |
STAT2
|
ENSG00000170581.9 | signal transducer and activator of transcription 2 |
IRF8
|
ENSG00000140968.6 | interferon regulatory factor 8 |
IRF1
|
ENSG00000125347.9 | interferon regulatory factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF1 | hg19_v2_chr5_-_131826457_131826514 | 0.77 | 3.1e-44 | Click! |
IRF2 | hg19_v2_chr4_-_185395672_185395734 | 0.72 | 1.2e-36 | Click! |
IRF8 | hg19_v2_chr16_+_85942594_85942635 | 0.56 | 1.6e-19 | Click! |
STAT2 | hg19_v2_chr12_-_56753858_56753930 | 0.02 | 8.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_32821924 | 199.84 |
ENST00000374859.2
ENST00000453265.2 |
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr1_+_948803 | 165.30 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr16_-_67970990 | 147.63 |
ENST00000358514.4
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
chr11_-_615942 | 126.93 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr6_-_33282163 | 109.81 |
ENST00000434618.2
ENST00000456592.2 |
TAPBP
|
TAP binding protein (tapasin) |
chr21_+_42733870 | 106.90 |
ENST00000330714.3
ENST00000436410.1 ENST00000435611.1 |
MX2
|
myxovirus (influenza virus) resistance 2 (mouse) |
chr6_+_32811885 | 105.61 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
chr6_-_32811771 | 104.75 |
ENST00000395339.3
ENST00000374882.3 |
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 |
chr19_-_17516449 | 98.27 |
ENST00000252593.6
|
BST2
|
bone marrow stromal cell antigen 2 |
chr1_+_158979792 | 95.71 |
ENST00000359709.3
ENST00000430894.2 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr1_+_158979680 | 92.83 |
ENST00000368131.4
ENST00000340979.6 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr1_+_158979686 | 92.43 |
ENST00000368132.3
ENST00000295809.7 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr11_-_615570 | 89.81 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr19_+_1077393 | 89.17 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr1_+_174843548 | 87.50 |
ENST00000478442.1
ENST00000465412.1 |
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr2_-_231084820 | 87.29 |
ENST00000258382.5
ENST00000338556.3 |
SP110
|
SP110 nuclear body protein |
chr7_+_74188309 | 85.50 |
ENST00000289473.4
ENST00000433458.1 |
NCF1
|
neutrophil cytosolic factor 1 |
chr6_-_32821599 | 82.69 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr21_+_42792442 | 77.84 |
ENST00000398600.2
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr10_-_91174215 | 76.32 |
ENST00000371837.1
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase |
chr1_+_79086088 | 74.45 |
ENST00000370751.5
ENST00000342282.3 |
IFI44L
|
interferon-induced protein 44-like |
chr1_+_79115503 | 68.63 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr14_+_58711539 | 67.56 |
ENST00000216455.4
ENST00000412908.2 ENST00000557508.1 |
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3 |
chr11_+_5710919 | 65.61 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr6_+_26365443 | 65.00 |
ENST00000527422.1
ENST00000356386.2 ENST00000396934.3 ENST00000377708.2 ENST00000396948.1 ENST00000508906.2 |
BTN3A2
|
butyrophilin, subfamily 3, member A2 |
chr6_+_6588902 | 61.35 |
ENST00000230568.4
|
LY86
|
lymphocyte antigen 86 |
chr6_+_26440700 | 59.85 |
ENST00000494393.1
ENST00000482451.1 ENST00000244519.2 ENST00000339789.4 ENST00000471353.1 ENST00000361232.3 ENST00000487627.1 ENST00000496719.1 ENST00000490254.1 ENST00000487272.1 |
BTN3A3
|
butyrophilin, subfamily 3, member A3 |
chr2_+_201981527 | 59.52 |
ENST00000441224.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr2_-_231084659 | 59.29 |
ENST00000258381.6
ENST00000358662.4 ENST00000455674.1 ENST00000392048.3 |
SP110
|
SP110 nuclear body protein |
chr12_+_25205446 | 58.58 |
ENST00000557489.1
ENST00000354454.3 ENST00000536173.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr2_-_231084617 | 58.00 |
ENST00000409815.2
|
SP110
|
SP110 nuclear body protein |
chr16_-_88851618 | 56.96 |
ENST00000301015.9
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1 |
chr12_-_49319265 | 56.70 |
ENST00000552878.1
ENST00000453172.2 |
FKBP11
|
FK506 binding protein 11, 19 kDa |
chr12_-_49318715 | 55.78 |
ENST00000444214.2
|
FKBP11
|
FK506 binding protein 11, 19 kDa |
chr3_-_49851313 | 55.60 |
ENST00000333486.3
|
UBA7
|
ubiquitin-like modifier activating enzyme 7 |
chr13_+_50070077 | 55.38 |
ENST00000378319.3
ENST00000426879.1 |
PHF11
|
PHD finger protein 11 |
chr15_+_45003675 | 54.91 |
ENST00000558401.1
ENST00000559916.1 ENST00000544417.1 |
B2M
|
beta-2-microglobulin |
chr4_+_147096837 | 54.82 |
ENST00000296581.5
ENST00000502781.1 |
LSM6
|
LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
chr14_+_24605361 | 54.82 |
ENST00000206451.6
ENST00000559123.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr12_+_113416191 | 54.61 |
ENST00000342315.4
ENST00000392583.2 |
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr14_+_24605389 | 54.55 |
ENST00000382708.3
ENST00000561435.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr14_-_100841930 | 53.66 |
ENST00000555031.1
ENST00000553395.1 ENST00000553545.1 ENST00000344102.5 ENST00000556338.1 ENST00000392882.2 ENST00000553934.1 |
WARS
|
tryptophanyl-tRNA synthetase |
chr11_-_57335280 | 53.58 |
ENST00000287156.4
|
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
chr13_+_50070491 | 53.48 |
ENST00000496612.1
ENST00000357596.3 ENST00000485919.1 ENST00000442195.1 |
PHF11
|
PHD finger protein 11 |
chr2_-_152146385 | 52.52 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
chr14_-_100841670 | 51.94 |
ENST00000557297.1
ENST00000555813.1 ENST00000557135.1 ENST00000556698.1 ENST00000554509.1 ENST00000555410.1 |
WARS
|
tryptophanyl-tRNA synthetase |
chr15_+_89182178 | 51.77 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr1_-_154580616 | 49.69 |
ENST00000368474.4
|
ADAR
|
adenosine deaminase, RNA-specific |
chr11_-_104905840 | 49.21 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr6_-_31324943 | 49.20 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr12_+_113344755 | 48.62 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr2_-_191878874 | 48.34 |
ENST00000392322.3
ENST00000392323.2 ENST00000424722.1 ENST00000361099.3 |
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr20_+_388935 | 48.27 |
ENST00000382181.2
ENST00000400247.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr11_-_104972158 | 47.92 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr19_+_18284477 | 47.48 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr15_+_89181974 | 46.67 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr4_-_185395672 | 46.43 |
ENST00000393593.3
|
IRF2
|
interferon regulatory factor 2 |
chr8_+_144640477 | 46.15 |
ENST00000262580.4
|
GSDMD
|
gasdermin D |
chr1_+_12227035 | 46.04 |
ENST00000376259.3
ENST00000536782.1 |
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B |
chr16_-_31214051 | 45.49 |
ENST00000350605.4
|
PYCARD
|
PYD and CARD domain containing |
chr1_-_151319710 | 43.22 |
ENST00000290524.4
ENST00000437327.1 ENST00000452513.2 ENST00000368870.2 ENST00000452671.2 |
RFX5
|
regulatory factor X, 5 (influences HLA class II expression) |
chr3_-_49142178 | 43.20 |
ENST00000452739.1
ENST00000414533.1 ENST00000417025.1 |
QARS
|
glutaminyl-tRNA synthetase |
chrX_+_123095546 | 42.53 |
ENST00000371157.3
ENST00000371145.3 ENST00000371144.3 |
STAG2
|
stromal antigen 2 |
chr3_-_49142504 | 41.70 |
ENST00000306125.6
ENST00000420147.2 |
QARS
|
glutaminyl-tRNA synthetase |
chr11_+_63304273 | 40.67 |
ENST00000439013.2
ENST00000255688.3 |
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3 |
chr19_+_10196781 | 38.71 |
ENST00000253110.11
|
C19orf66
|
chromosome 19 open reading frame 66 |
chr5_-_95158375 | 38.59 |
ENST00000512469.2
ENST00000379979.4 ENST00000505427.1 ENST00000508780.1 |
GLRX
|
glutaredoxin (thioltransferase) |
chr17_+_46908350 | 38.00 |
ENST00000258947.3
ENST00000509507.1 ENST00000448105.2 ENST00000570513.1 ENST00000509415.1 ENST00000513119.1 ENST00000416445.2 ENST00000508679.1 ENST00000505071.1 |
CALCOCO2
|
calcium binding and coiled-coil domain 2 |
chrX_+_37639264 | 37.66 |
ENST00000378588.4
|
CYBB
|
cytochrome b-245, beta polypeptide |
chr1_+_179050512 | 34.86 |
ENST00000367627.3
|
TOR3A
|
torsin family 3, member A |
chr20_+_388679 | 34.67 |
ENST00000356286.5
ENST00000475269.1 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr1_+_158801095 | 34.59 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr21_+_42798094 | 34.58 |
ENST00000398598.3
ENST00000455164.2 ENST00000424365.1 |
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr1_-_89531041 | 34.47 |
ENST00000370473.4
|
GBP1
|
guanylate binding protein 1, interferon-inducible |
chr2_-_191878681 | 34.37 |
ENST00000409465.1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr16_+_12058961 | 34.10 |
ENST00000053243.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr2_+_231280908 | 33.74 |
ENST00000427101.2
ENST00000432979.1 |
SP100
|
SP100 nuclear antigen |
chr2_+_120687335 | 33.70 |
ENST00000544261.1
|
PTPN4
|
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
chr18_+_3262954 | 32.51 |
ENST00000584539.1
|
MYL12B
|
myosin, light chain 12B, regulatory |
chr4_+_37892682 | 31.49 |
ENST00000508802.1
ENST00000261439.4 ENST00000402522.1 |
TBC1D1
|
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
chr5_-_95158644 | 31.48 |
ENST00000237858.6
|
GLRX
|
glutaredoxin (thioltransferase) |
chr17_+_25958174 | 31.12 |
ENST00000313648.6
ENST00000577392.1 ENST00000584661.1 ENST00000413914.2 |
LGALS9
|
lectin, galactoside-binding, soluble, 9 |
chr16_+_12059050 | 30.85 |
ENST00000396495.3
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr15_+_89182156 | 30.09 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr12_+_25205666 | 29.97 |
ENST00000547044.1
|
LRMP
|
lymphoid-restricted membrane protein |
chr6_-_41909191 | 29.60 |
ENST00000512426.1
ENST00000372987.4 |
CCND3
|
cyclin D3 |
chr12_-_10022735 | 28.50 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr20_-_5100591 | 28.47 |
ENST00000379143.5
|
PCNA
|
proliferating cell nuclear antigen |
chr15_+_78832747 | 28.41 |
ENST00000560217.1
ENST00000044462.7 ENST00000559082.1 ENST00000559948.1 ENST00000413382.2 ENST00000559146.1 ENST00000558281.1 |
PSMA4
|
proteasome (prosome, macropain) subunit, alpha type, 4 |
chr2_+_201981119 | 28.27 |
ENST00000395148.2
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr12_+_6561190 | 28.10 |
ENST00000544021.1
ENST00000266556.7 |
TAPBPL
|
TAP binding protein-like |
chr16_+_12059091 | 27.90 |
ENST00000562385.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr6_-_159239257 | 27.88 |
ENST00000337147.7
ENST00000392177.4 |
EZR
|
ezrin |
chr12_+_94542459 | 27.80 |
ENST00000258526.4
|
PLXNC1
|
plexin C1 |
chr5_+_49962495 | 27.73 |
ENST00000515175.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr5_+_96212185 | 27.52 |
ENST00000379904.4
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr3_+_63898275 | 26.98 |
ENST00000538065.1
|
ATXN7
|
ataxin 7 |
chr3_-_146262488 | 26.32 |
ENST00000487389.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr12_+_25205568 | 26.11 |
ENST00000548766.1
ENST00000556887.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr12_+_113344811 | 26.10 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr5_+_96211643 | 26.01 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr9_-_100881466 | 25.97 |
ENST00000341469.2
ENST00000342043.3 ENST00000375098.3 |
TRIM14
|
tripartite motif containing 14 |
chr5_-_142783694 | 25.74 |
ENST00000394466.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr14_+_35452104 | 25.73 |
ENST00000216774.6
ENST00000546080.1 |
SRP54
|
signal recognition particle 54kDa |
chr11_-_4414880 | 25.57 |
ENST00000254436.7
ENST00000543625.1 |
TRIM21
|
tripartite motif containing 21 |
chr10_+_91087651 | 25.53 |
ENST00000371818.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr1_-_111746966 | 25.32 |
ENST00000369752.5
|
DENND2D
|
DENN/MADD domain containing 2D |
chr2_+_201994569 | 25.27 |
ENST00000457277.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr14_-_24615805 | 25.18 |
ENST00000560410.1
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr11_-_67169253 | 25.12 |
ENST00000527663.1
ENST00000312989.7 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
chr6_+_37400974 | 24.53 |
ENST00000455891.1
ENST00000373451.4 |
CMTR1
|
cap methyltransferase 1 |
chr3_-_172241250 | 24.39 |
ENST00000420541.2
ENST00000241261.2 |
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10 |
chr3_-_30936153 | 24.11 |
ENST00000454381.3
ENST00000282538.5 |
GADL1
|
glutamate decarboxylase-like 1 |
chr14_+_24630465 | 23.98 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr3_-_146262365 | 23.86 |
ENST00000448787.2
|
PLSCR1
|
phospholipid scramblase 1 |
chr14_+_35452169 | 23.75 |
ENST00000555557.1
|
SRP54
|
signal recognition particle 54kDa |
chr16_+_29831715 | 23.67 |
ENST00000563915.1
ENST00000357402.5 |
MVP
|
major vault protein |
chr11_-_60719213 | 23.57 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr6_+_25963020 | 23.31 |
ENST00000357085.3
|
TRIM38
|
tripartite motif containing 38 |
chr18_+_48405463 | 23.16 |
ENST00000382927.3
|
ME2
|
malic enzyme 2, NAD(+)-dependent, mitochondrial |
chr11_+_1874200 | 22.96 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
chr12_-_53594227 | 22.83 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
chr3_-_121379739 | 22.76 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr14_+_73563735 | 22.76 |
ENST00000532192.1
|
RBM25
|
RNA binding motif protein 25 |
chr16_-_75681522 | 22.75 |
ENST00000568378.1
ENST00000568682.1 ENST00000570215.1 ENST00000319410.5 ENST00000302445.3 |
KARS
|
lysyl-tRNA synthetase |
chr16_+_29831757 | 22.71 |
ENST00000452209.2
ENST00000395353.1 ENST00000566066.1 ENST00000563558.1 |
MVP
|
major vault protein |
chrX_+_37639302 | 22.61 |
ENST00000545017.1
ENST00000536160.1 |
CYBB
|
cytochrome b-245, beta polypeptide |
chr17_+_6659153 | 22.57 |
ENST00000441631.1
ENST00000438512.1 ENST00000346752.4 ENST00000361842.3 |
XAF1
|
XIAP associated factor 1 |
chr7_-_138794081 | 22.47 |
ENST00000464606.1
|
ZC3HAV1
|
zinc finger CCCH-type, antiviral 1 |
chr2_+_201994208 | 22.23 |
ENST00000440180.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr15_-_80263506 | 21.81 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr12_-_31479045 | 21.74 |
ENST00000539409.1
ENST00000395766.1 |
FAM60A
|
family with sequence similarity 60, member A |
chr5_-_149792295 | 21.60 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr12_+_113344582 | 21.60 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr18_+_48405419 | 21.49 |
ENST00000321341.5
|
ME2
|
malic enzyme 2, NAD(+)-dependent, mitochondrial |
chr1_-_25291475 | 21.43 |
ENST00000338888.3
ENST00000399916.1 |
RUNX3
|
runt-related transcription factor 3 |
chr3_-_146262428 | 21.30 |
ENST00000486631.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr6_-_32920794 | 21.18 |
ENST00000395305.3
ENST00000395303.3 ENST00000374843.4 ENST00000429234.1 |
HLA-DMA
XXbac-BPG181M17.5
|
major histocompatibility complex, class II, DM alpha Uncharacterized protein |
chr2_+_201994042 | 21.15 |
ENST00000417748.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr22_+_39436862 | 21.08 |
ENST00000381565.2
ENST00000452957.2 |
APOBEC3F
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G |
chr3_+_151986709 | 21.08 |
ENST00000495875.2
ENST00000493459.1 ENST00000324210.5 ENST00000459747.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr1_-_27998689 | 21.00 |
ENST00000339145.4
ENST00000362020.4 ENST00000361157.6 |
IFI6
|
interferon, alpha-inducible protein 6 |
chr4_-_103748271 | 20.85 |
ENST00000343106.5
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr2_+_202122703 | 20.82 |
ENST00000447616.1
ENST00000358485.4 |
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr6_+_29691198 | 20.77 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr5_-_96143602 | 20.55 |
ENST00000443439.2
ENST00000503921.1 ENST00000508227.1 ENST00000507154.1 |
ERAP1
|
endoplasmic reticulum aminopeptidase 1 |
chr1_+_165864800 | 20.47 |
ENST00000469256.2
|
UCK2
|
uridine-cytidine kinase 2 |
chr10_+_91152303 | 20.46 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr2_+_86669118 | 20.30 |
ENST00000427678.1
ENST00000542128.1 |
KDM3A
|
lysine (K)-specific demethylase 3A |
chr6_+_26402465 | 20.29 |
ENST00000476549.2
ENST00000289361.6 ENST00000450085.2 ENST00000425234.2 ENST00000427334.1 ENST00000506698.1 |
BTN3A1
|
butyrophilin, subfamily 3, member A1 |
chr6_+_29691056 | 20.16 |
ENST00000414333.1
ENST00000334668.4 ENST00000259951.7 |
HLA-F
|
major histocompatibility complex, class I, F |
chr17_-_40264692 | 20.14 |
ENST00000591220.1
ENST00000251642.3 |
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr2_+_231191875 | 20.11 |
ENST00000444636.1
ENST00000415673.2 ENST00000243810.6 ENST00000396563.4 |
SP140L
|
SP140 nuclear body protein-like |
chr19_+_49838653 | 19.98 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr11_-_14358620 | 19.92 |
ENST00000531421.1
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2 |
chr11_+_5646213 | 19.83 |
ENST00000429814.2
|
TRIM34
|
tripartite motif containing 34 |
chr5_+_118690466 | 19.51 |
ENST00000503646.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr14_-_35099315 | 19.50 |
ENST00000396526.3
ENST00000396534.3 ENST00000355110.5 ENST00000557265.1 |
SNX6
|
sorting nexin 6 |
chr2_+_85811525 | 19.36 |
ENST00000306384.4
|
VAMP5
|
vesicle-associated membrane protein 5 |
chr2_+_86668464 | 19.31 |
ENST00000409064.1
|
KDM3A
|
lysine (K)-specific demethylase 3A |
chr3_+_152017181 | 19.04 |
ENST00000498502.1
ENST00000324196.5 ENST00000545754.1 ENST00000357472.3 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr14_+_91580777 | 18.79 |
ENST00000525393.2
ENST00000428926.2 ENST00000517362.1 |
C14orf159
|
chromosome 14 open reading frame 159 |
chr4_-_83765613 | 18.75 |
ENST00000503937.1
|
SEC31A
|
SEC31 homolog A (S. cerevisiae) |
chr17_+_18380051 | 18.38 |
ENST00000581545.1
ENST00000582333.1 ENST00000328114.6 ENST00000412421.2 ENST00000583322.1 ENST00000584941.1 |
LGALS9C
|
lectin, galactoside-binding, soluble, 9C |
chr1_+_165864821 | 18.36 |
ENST00000470820.1
|
UCK2
|
uridine-cytidine kinase 2 |
chr6_-_170862322 | 18.32 |
ENST00000262193.6
|
PSMB1
|
proteasome (prosome, macropain) subunit, beta type, 1 |
chr14_+_91581011 | 18.30 |
ENST00000523894.1
ENST00000522322.1 ENST00000523771.1 |
C14orf159
|
chromosome 14 open reading frame 159 |
chr13_+_53216565 | 18.21 |
ENST00000357495.2
|
HNRNPA1L2
|
heterogeneous nuclear ribonucleoprotein A1-like 2 |
chr17_-_5342380 | 18.01 |
ENST00000225698.4
|
C1QBP
|
complement component 1, q subcomponent binding protein |
chr6_-_26056695 | 17.79 |
ENST00000343677.2
|
HIST1H1C
|
histone cluster 1, H1c |
chr3_-_146262352 | 17.36 |
ENST00000462666.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr3_-_146262637 | 17.35 |
ENST00000472349.1
ENST00000342435.4 |
PLSCR1
|
phospholipid scramblase 1 |
chr6_-_31239846 | 17.25 |
ENST00000415537.1
ENST00000376228.5 ENST00000383329.3 |
HLA-C
|
major histocompatibility complex, class I, C |
chr4_-_103747011 | 17.19 |
ENST00000350435.7
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr11_-_73687997 | 17.19 |
ENST00000545212.1
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr4_-_103746683 | 16.88 |
ENST00000504211.1
ENST00000508476.1 |
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr11_+_60223225 | 16.76 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr14_+_91580732 | 16.75 |
ENST00000519019.1
ENST00000523816.1 ENST00000517518.1 |
C14orf159
|
chromosome 14 open reading frame 159 |
chr1_+_64058939 | 16.73 |
ENST00000371084.3
|
PGM1
|
phosphoglucomutase 1 |
chr1_-_153919128 | 16.68 |
ENST00000361217.4
|
DENND4B
|
DENN/MADD domain containing 4B |
chr11_-_65381643 | 16.61 |
ENST00000309100.3
ENST00000529839.1 ENST00000526293.1 |
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11 |
chr3_-_167452262 | 16.53 |
ENST00000487947.2
|
PDCD10
|
programmed cell death 10 |
chr1_-_19426149 | 16.45 |
ENST00000429347.2
|
UBR4
|
ubiquitin protein ligase E3 component n-recognin 4 |
chr12_+_75874460 | 16.36 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr11_+_313503 | 16.35 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr11_+_60223312 | 16.14 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr1_+_158149737 | 16.00 |
ENST00000368171.3
|
CD1D
|
CD1d molecule |
chr22_-_36556821 | 15.91 |
ENST00000531095.1
ENST00000397293.2 ENST00000349314.2 |
APOL3
|
apolipoprotein L, 3 |
chr3_-_146262293 | 15.71 |
ENST00000448205.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr2_-_225434538 | 15.71 |
ENST00000409096.1
|
CUL3
|
cullin 3 |
chr17_+_41158742 | 15.65 |
ENST00000415816.2
ENST00000438323.2 |
IFI35
|
interferon-induced protein 35 |
chr11_-_67169265 | 15.24 |
ENST00000358239.4
ENST00000376745.4 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
chrX_+_80457442 | 15.18 |
ENST00000373212.5
|
SH3BGRL
|
SH3 domain binding glutamic acid-rich protein like |
chr3_+_38179969 | 15.11 |
ENST00000396334.3
ENST00000417037.2 ENST00000424893.1 ENST00000495303.1 ENST00000443433.2 ENST00000421516.1 |
MYD88
|
myeloid differentiation primary response 88 |
chr5_+_133861790 | 15.03 |
ENST00000395003.1
|
PHF15
|
jade family PHD finger 2 |
chr16_+_50776021 | 14.98 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chrX_-_20236970 | 14.97 |
ENST00000379548.4
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
chrX_+_70503037 | 14.97 |
ENST00000535149.1
|
NONO
|
non-POU domain containing, octamer-binding |
chr10_+_51572408 | 14.95 |
ENST00000374082.1
|
NCOA4
|
nuclear receptor coactivator 4 |
chr9_-_32526184 | 14.92 |
ENST00000545044.1
ENST00000379868.1 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
44.8 | 223.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
42.8 | 128.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
34.3 | 274.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
32.8 | 98.3 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) negative regulation of intracellular transport of viral material(GO:1901253) |
28.3 | 84.9 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
28.1 | 28.1 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
25.4 | 101.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
21.6 | 280.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
21.1 | 105.6 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
20.7 | 82.7 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
19.9 | 219.3 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
19.0 | 57.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
17.5 | 52.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
16.6 | 49.7 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
16.5 | 49.5 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
15.4 | 46.2 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
15.2 | 121.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
15.2 | 152.2 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
15.2 | 45.5 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
13.8 | 69.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
13.2 | 39.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
12.1 | 60.3 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
11.8 | 11.8 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
11.6 | 46.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
11.5 | 46.1 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
11.5 | 103.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
11.2 | 67.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
11.1 | 89.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
10.4 | 1007.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
10.1 | 40.4 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
9.7 | 38.8 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
9.5 | 47.3 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
9.0 | 27.0 | GO:0039516 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
8.8 | 70.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
7.8 | 54.6 | GO:0018377 | protein myristoylation(GO:0018377) |
7.8 | 31.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
7.6 | 22.8 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
7.3 | 22.0 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
7.1 | 28.5 | GO:1902990 | leading strand elongation(GO:0006272) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
6.9 | 27.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
6.8 | 20.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
6.7 | 6.7 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
6.6 | 39.7 | GO:1901098 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
6.6 | 32.9 | GO:0072642 | positive regulation of interferon-beta secretion(GO:0035549) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
6.4 | 44.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
5.9 | 293.4 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
5.7 | 22.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
5.3 | 21.2 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
4.9 | 24.5 | GO:0080009 | mRNA methylation(GO:0080009) |
4.9 | 24.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
4.6 | 36.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
4.5 | 49.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
4.4 | 35.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
4.4 | 35.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
4.3 | 17.4 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
4.3 | 13.0 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
4.1 | 12.3 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
4.0 | 16.0 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
4.0 | 23.8 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
3.9 | 15.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
3.9 | 19.5 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
3.9 | 70.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
3.8 | 46.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
3.8 | 15.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
3.7 | 43.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
3.6 | 10.9 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
3.6 | 10.9 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
3.6 | 82.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
3.6 | 14.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
3.3 | 23.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
3.3 | 23.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
3.2 | 12.8 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
3.1 | 12.4 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
2.9 | 8.8 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
2.9 | 11.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
2.9 | 8.7 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
2.9 | 20.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
2.8 | 2.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
2.8 | 25.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
2.8 | 16.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.7 | 8.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
2.7 | 10.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.6 | 15.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.6 | 7.9 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
2.6 | 10.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
2.6 | 46.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
2.5 | 7.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.5 | 7.4 | GO:0032621 | central nervous system myelin formation(GO:0032289) interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
2.5 | 17.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.5 | 12.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.4 | 116.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
2.4 | 16.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.4 | 9.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
2.3 | 106.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
2.2 | 29.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
2.2 | 10.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
2.2 | 8.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
2.2 | 6.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
2.1 | 10.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
2.1 | 4.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
2.0 | 13.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
2.0 | 4.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.9 | 5.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
1.9 | 7.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.9 | 15.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.9 | 5.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.9 | 3.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.9 | 5.6 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
1.8 | 3.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.8 | 5.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.8 | 34.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.8 | 5.4 | GO:0071283 | cellular response to iron(III) ion(GO:0071283) |
1.8 | 32.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
1.8 | 3.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.8 | 10.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.7 | 6.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.7 | 39.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.7 | 76.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.7 | 5.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.7 | 9.9 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.7 | 5.0 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
1.6 | 95.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
1.6 | 8.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.6 | 19.6 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
1.6 | 14.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.6 | 19.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
1.6 | 9.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.6 | 14.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.5 | 7.7 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
1.5 | 63.1 | GO:0006536 | glutamate metabolic process(GO:0006536) |
1.5 | 5.9 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.5 | 7.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
1.5 | 2.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.5 | 2.9 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
1.5 | 2.9 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
1.4 | 5.8 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
1.4 | 53.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
1.4 | 114.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
1.4 | 18.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
1.4 | 15.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.4 | 6.8 | GO:0070836 | caveola assembly(GO:0070836) |
1.4 | 13.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
1.3 | 4.0 | GO:0002384 | hepatic immune response(GO:0002384) |
1.3 | 4.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
1.3 | 6.7 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.3 | 140.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
1.3 | 3.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.2 | 13.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.2 | 26.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.2 | 100.3 | GO:0006906 | vesicle fusion(GO:0006906) |
1.2 | 4.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.2 | 3.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.2 | 4.7 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
1.2 | 6.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) basic amino acid transmembrane transport(GO:1990822) |
1.1 | 21.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.1 | 6.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.1 | 3.3 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
1.0 | 1.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.0 | 3.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.0 | 5.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.0 | 1.0 | GO:0048087 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.0 | 2.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
1.0 | 4.8 | GO:0097338 | response to clozapine(GO:0097338) |
1.0 | 7.6 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.9 | 18.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.9 | 0.9 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.9 | 8.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.9 | 10.6 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.9 | 3.5 | GO:0043335 | protein unfolding(GO:0043335) |
0.9 | 10.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.9 | 4.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.9 | 11.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.9 | 5.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.8 | 7.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.8 | 5.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.8 | 4.9 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.8 | 14.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.8 | 4.0 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.8 | 5.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.8 | 28.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.8 | 11.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.8 | 6.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.8 | 12.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.8 | 7.7 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.8 | 7.6 | GO:0015886 | heme transport(GO:0015886) |
0.8 | 3.8 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.8 | 6.0 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.8 | 3.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.7 | 14.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.7 | 5.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.7 | 2.2 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.7 | 2.2 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.7 | 37.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.7 | 15.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.7 | 7.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.7 | 3.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.7 | 15.0 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.7 | 2.8 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.7 | 3.4 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.7 | 11.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.7 | 5.4 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.6 | 5.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.6 | 3.8 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.6 | 16.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.6 | 3.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.6 | 1.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.6 | 1.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 14.9 | GO:0003094 | glomerular filtration(GO:0003094) |
0.6 | 10.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 11.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.6 | 27.7 | GO:0006298 | mismatch repair(GO:0006298) |
0.6 | 29.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.6 | 3.3 | GO:1990441 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.6 | 3.9 | GO:0097319 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.6 | 4.4 | GO:0015867 | ADP transport(GO:0015866) ATP transport(GO:0015867) adenine nucleotide transport(GO:0051503) |
0.5 | 4.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 10.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.5 | 7.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 9.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.5 | 0.5 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.5 | 2.0 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.5 | 10.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 6.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 6.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 10.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 1.9 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.5 | 30.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.4 | 1.3 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.4 | 4.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 4.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 6.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.4 | 12.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 2.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.4 | 1.2 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.4 | 1.2 | GO:0070541 | response to platinum ion(GO:0070541) |
0.4 | 1.5 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 2.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 2.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 4.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 3.3 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.4 | 1.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 10.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.3 | 35.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 13.0 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.3 | 2.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 9.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 1.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 6.1 | GO:0032418 | lysosome localization(GO:0032418) |
0.3 | 5.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.3 | 0.6 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 1.2 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.3 | 3.3 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 5.7 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 45.1 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.3 | 1.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 2.6 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.3 | 0.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.3 | 1.1 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.3 | 3.7 | GO:0043583 | ear development(GO:0043583) inner ear development(GO:0048839) |
0.3 | 5.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 0.8 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.3 | 6.1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.3 | 1.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 6.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 1.4 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.3 | 6.3 | GO:0014904 | myotube cell development(GO:0014904) |
0.3 | 0.8 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.3 | 1.0 | GO:0090309 | regulation of methylation-dependent chromatin silencing(GO:0090308) positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 2.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 4.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 8.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 1.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 13.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 3.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 6.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 10.5 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.2 | 7.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 6.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 15.8 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.2 | 11.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 3.0 | GO:0003014 | renal system process(GO:0003014) |
0.2 | 29.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 6.5 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 8.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 5.5 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 2.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 5.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.2 | 2.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 12.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 5.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 3.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 1.0 | GO:0051012 | microtubule sliding(GO:0051012) |
0.2 | 4.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 3.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 8.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 0.5 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.2 | 0.5 | GO:0001897 | cytolysis by symbiont of host cells(GO:0001897) hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 3.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 9.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
0.1 | 0.3 | GO:0071698 | olfactory placode formation(GO:0030910) ureteric bud formation(GO:0060676) cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) mesonephric tubule formation(GO:0072172) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 7.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 1.6 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.6 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 11.5 | GO:0008652 | cellular amino acid biosynthetic process(GO:0008652) |
0.1 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 1.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 8.3 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.7 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.1 | 5.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 53.9 | GO:0016032 | viral process(GO:0016032) |
0.1 | 1.6 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 3.1 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 1.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 2.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 1.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 2.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 1.1 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.1 | 2.5 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 1.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 4.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
0.1 | 0.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 9.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 4.1 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 2.7 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 3.2 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 3.6 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.7 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.0 | 0.1 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.0 | 2.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 3.2 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 3.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 1.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.2 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.2 | GO:0043473 | pigmentation(GO:0043473) |
0.0 | 0.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 1.2 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 1.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 2.4 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
69.7 | 557.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
30.6 | 183.7 | GO:0042825 | TAP complex(GO:0042825) |
24.4 | 146.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
23.8 | 142.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
17.8 | 89.1 | GO:0071797 | LUBAC complex(GO:0071797) |
11.8 | 129.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
11.5 | 34.5 | GO:0044393 | microspike(GO:0044393) |
10.7 | 85.5 | GO:0032010 | phagolysosome(GO:0032010) |
9.9 | 49.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
9.7 | 116.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
9.6 | 173.1 | GO:0097342 | ripoptosome(GO:0097342) |
9.5 | 28.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
7.0 | 21.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
6.7 | 53.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
6.2 | 130.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
6.2 | 49.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
5.7 | 22.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
5.7 | 34.0 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
5.6 | 39.0 | GO:0030870 | Mre11 complex(GO:0030870) |
5.0 | 54.8 | GO:0005688 | U6 snRNP(GO:0005688) |
5.0 | 14.9 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
4.6 | 59.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
4.3 | 34.1 | GO:0043196 | varicosity(GO:0043196) |
4.0 | 40.5 | GO:0042587 | glycogen granule(GO:0042587) |
4.0 | 32.1 | GO:0070552 | BRISC complex(GO:0070552) |
3.7 | 11.2 | GO:0036398 | TCR signalosome(GO:0036398) |
3.2 | 29.0 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
3.1 | 21.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
3.0 | 14.8 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
2.9 | 202.5 | GO:0015030 | Cajal body(GO:0015030) |
2.9 | 14.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
2.8 | 205.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
2.8 | 8.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
2.6 | 7.7 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
2.5 | 7.4 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
2.5 | 27.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.4 | 7.3 | GO:0031213 | RSF complex(GO:0031213) |
2.4 | 28.9 | GO:0044754 | autolysosome(GO:0044754) |
2.4 | 7.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
2.2 | 4.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
2.0 | 8.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.9 | 15.0 | GO:0042382 | paraspeckles(GO:0042382) |
1.8 | 60.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.8 | 3.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.8 | 8.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.7 | 15.7 | GO:0005827 | polar microtubule(GO:0005827) |
1.7 | 11.6 | GO:0072487 | MSL complex(GO:0072487) |
1.5 | 10.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
1.4 | 13.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.3 | 162.6 | GO:0005643 | nuclear pore(GO:0005643) |
1.3 | 12.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.3 | 5.0 | GO:0070985 | TFIIK complex(GO:0070985) |
1.2 | 11.1 | GO:0032039 | integrator complex(GO:0032039) |
1.2 | 3.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
1.1 | 10.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.1 | 7.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.1 | 30.2 | GO:0070822 | Sin3-type complex(GO:0070822) |
1.1 | 7.7 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
1.1 | 38.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.1 | 21.2 | GO:0042611 | MHC protein complex(GO:0042611) |
1.0 | 8.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.0 | 4.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.0 | 5.0 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.9 | 4.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.9 | 26.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.9 | 59.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 7.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.8 | 18.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.8 | 8.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.8 | 9.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.8 | 338.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.7 | 8.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.7 | 15.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.7 | 13.2 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.7 | 21.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 32.5 | GO:0099738 | cell cortex region(GO:0099738) |
0.7 | 4.9 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.7 | 2.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.6 | 1.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 17.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.6 | 5.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.6 | 3.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 10.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.6 | 57.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.6 | 14.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.6 | 13.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.6 | 100.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.6 | 8.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 4.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.6 | 10.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.6 | 11.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.6 | 179.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.5 | 2.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.5 | 10.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 232.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.5 | 27.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 1.9 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.5 | 64.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 19.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 1.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.8 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.4 | 4.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 11.9 | GO:0005776 | autophagosome(GO:0005776) |
0.4 | 76.6 | GO:0005769 | early endosome(GO:0005769) |
0.4 | 3.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 5.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 3.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 4.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 6.3 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 5.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 28.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.4 | 24.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 17.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 10.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 30.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 172.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 14.0 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 2.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 8.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 7.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 4.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 83.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.3 | 4.5 | GO:0032059 | bleb(GO:0032059) |
0.3 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.3 | 6.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 3.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 31.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 6.2 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 2.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 3.4 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.2 | 1.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 1.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 23.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 3.1 | GO:0031105 | septin complex(GO:0031105) |
0.2 | 3.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 2.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 7.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 7.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 23.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 3.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 4.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 1.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 20.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 16.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 5.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 42.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 6.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 10.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 2.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 11.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 16.0 | GO:0005635 | nuclear envelope(GO:0005635) |
0.2 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 11.7 | GO:0005814 | centriole(GO:0005814) |
0.1 | 1.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 8.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 51.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 15.2 | GO:0031968 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
0.1 | 7.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 13.0 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 99.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 5.3 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 10.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 3.7 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 99.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 8.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 1.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
42.8 | 128.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
38.2 | 228.9 | GO:0046979 | TAP2 binding(GO:0046979) |
28.3 | 84.9 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
23.4 | 703.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
21.1 | 105.6 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
20.9 | 146.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
15.3 | 76.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
15.2 | 45.5 | GO:0032090 | Pyrin domain binding(GO:0032090) |
13.8 | 165.3 | GO:0031386 | protein tag(GO:0031386) |
13.4 | 40.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
12.6 | 63.1 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
11.1 | 121.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
10.4 | 31.1 | GO:0048030 | disaccharide binding(GO:0048030) |
9.9 | 308.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
9.9 | 49.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
9.5 | 57.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
9.3 | 55.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
8.9 | 53.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
8.5 | 85.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
8.3 | 82.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
7.9 | 23.6 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
7.4 | 44.6 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
7.4 | 29.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
7.1 | 28.5 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
7.0 | 35.2 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
7.0 | 70.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
6.4 | 25.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
6.0 | 24.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
6.0 | 18.0 | GO:0030984 | kininogen binding(GO:0030984) |
5.9 | 29.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
5.8 | 46.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
5.5 | 38.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
5.4 | 21.5 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
5.1 | 46.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
4.9 | 24.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
4.2 | 16.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
4.1 | 103.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
4.0 | 16.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
3.9 | 15.7 | GO:0031208 | POZ domain binding(GO:0031208) |
3.9 | 113.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
3.9 | 19.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
3.8 | 22.6 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
3.5 | 42.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
3.3 | 20.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
3.3 | 59.8 | GO:0019864 | IgG binding(GO:0019864) |
3.3 | 16.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
3.1 | 9.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
3.1 | 18.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
3.0 | 8.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
2.9 | 14.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.9 | 49.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.9 | 17.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.7 | 8.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
2.6 | 7.9 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
2.5 | 7.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.4 | 266.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
2.4 | 33.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.4 | 7.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.3 | 6.8 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.2 | 91.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
2.2 | 8.8 | GO:0097001 | ceramide binding(GO:0097001) |
2.2 | 22.0 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
2.2 | 65.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
2.1 | 39.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.9 | 5.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.9 | 40.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.8 | 7.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
1.8 | 29.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.8 | 296.0 | GO:0001047 | core promoter binding(GO:0001047) |
1.8 | 16.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.8 | 19.5 | GO:0034452 | dynactin binding(GO:0034452) |
1.7 | 34.9 | GO:0044548 | S100 protein binding(GO:0044548) |
1.7 | 8.7 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
1.7 | 5.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
1.7 | 40.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
1.7 | 9.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.6 | 13.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.6 | 27.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.6 | 16.0 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
1.6 | 15.5 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.4 | 5.8 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
1.4 | 7.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
1.4 | 8.5 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.4 | 20.3 | GO:0031996 | thioesterase binding(GO:0031996) |
1.3 | 4.0 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.3 | 5.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.3 | 40.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.2 | 15.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.1 | 22.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
1.1 | 14.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.1 | 4.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
1.1 | 8.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
1.1 | 6.6 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
1.1 | 21.8 | GO:0051400 | BH domain binding(GO:0051400) |
1.1 | 36.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.1 | 7.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.0 | 7.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.0 | 13.6 | GO:0005123 | death receptor binding(GO:0005123) |
1.0 | 10.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
1.0 | 8.1 | GO:0089720 | caspase binding(GO:0089720) |
1.0 | 3.0 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
1.0 | 3.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.9 | 14.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.9 | 34.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 47.0 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.8 | 42.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.8 | 6.7 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 11.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.8 | 3.3 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.8 | 22.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.8 | 12.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.8 | 5.5 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.8 | 5.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.8 | 13.7 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.8 | 7.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.8 | 12.8 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 7.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.7 | 5.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.7 | 10.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.7 | 7.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.7 | 2.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.7 | 4.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 7.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.7 | 1.3 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.7 | 4.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.7 | 4.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 1.9 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.6 | 6.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.6 | 11.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 17.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.6 | 18.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.6 | 0.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.6 | 96.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.6 | 4.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 44.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.6 | 22.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.6 | 4.0 | GO:0019863 | IgE binding(GO:0019863) |
0.6 | 190.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.6 | 3.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.6 | 3.9 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.6 | 4.4 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
0.5 | 23.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 7.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 27.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.5 | 7.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.5 | 11.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.5 | 10.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 7.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 17.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 25.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 8.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 21.9 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.4 | 20.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 1.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 10.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 4.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.4 | 2.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 6.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 8.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.4 | 10.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 12.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 2.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 18.2 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 2.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 1.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 34.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 2.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.3 | 17.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.3 | 6.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 4.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 63.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 13.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 3.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 10.6 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.3 | 1.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 36.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.3 | 3.2 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.3 | 0.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.3 | 10.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 38.6 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 3.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 15.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 4.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 8.2 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 2.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 8.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 10.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 5.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.1 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.2 | 5.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 10.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 40.7 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.2 | 1.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 2.5 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 2.1 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.2 | 4.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 22.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 3.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 5.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 6.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 6.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 6.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 1.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 2.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 2.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 7.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 2.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 49.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 24.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 5.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 1.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 23.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 2.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 5.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 6.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 1.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 1.3 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 1.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 1.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 1.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 7.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 0.6 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.7 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 1.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 94.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
6.0 | 179.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
3.4 | 92.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.8 | 116.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
2.5 | 193.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.7 | 270.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.6 | 44.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.5 | 35.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.5 | 53.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.5 | 26.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.5 | 31.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.4 | 76.9 | PID AURORA B PATHWAY | Aurora B signaling |
1.2 | 79.1 | PID PLK1 PATHWAY | PLK1 signaling events |
1.2 | 68.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.0 | 30.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.0 | 37.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.9 | 22.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.9 | 68.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.9 | 39.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.8 | 37.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.8 | 7.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.8 | 28.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 15.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.7 | 19.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 103.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 5.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 20.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 20.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 12.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 21.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.5 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 10.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 10.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 13.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 2.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 47.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 19.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 12.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 24.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 11.9 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 5.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 17.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 9.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 4.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 3.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 3.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 4.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 3.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 2.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.8 | 231.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
17.0 | 170.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
11.6 | 855.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
10.1 | 808.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
7.6 | 143.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
7.0 | 203.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
6.6 | 235.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
5.2 | 244.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
4.9 | 82.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
4.5 | 66.9 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
3.6 | 53.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
2.4 | 28.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
2.3 | 21.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.2 | 70.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
2.1 | 40.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
2.0 | 36.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.4 | 17.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.3 | 36.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.2 | 35.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.1 | 27.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.1 | 16.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.1 | 38.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.1 | 9.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.0 | 21.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.0 | 20.5 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.9 | 17.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.9 | 18.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.9 | 41.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.9 | 20.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.8 | 83.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.8 | 43.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.8 | 60.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.7 | 25.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.7 | 10.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.7 | 31.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.7 | 14.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.7 | 34.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 6.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.6 | 11.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 114.5 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.6 | 16.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 14.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 46.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.6 | 5.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.5 | 66.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.5 | 21.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 5.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.5 | 4.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 36.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 7.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.5 | 29.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.5 | 35.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.4 | 6.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 27.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 6.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 47.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 62.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 8.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 19.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 11.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 3.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 36.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 7.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 9.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 9.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 7.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 15.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 5.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 4.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 22.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 4.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 5.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 3.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 8.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 5.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 3.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 6.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 7.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 6.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 3.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 10.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 5.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 13.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 2.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 2.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |